Specific immunotherapy in children is safe and effective (Letter to the Editor)

A. Cantani, G. Arcese, D. Gagliesi, P. Lucenti

University of Rome “La Sapienza” – Rome (Italy)

---

• Immunology

Abstract. – Pediatric SIT being not an optional treatment should be administered as soon as possible, also in children aged 2-3 years, due to the very early asthma and rhinitis onset, contrarily to a recent publication that continues to stress the danger of anaphylactic reactions without displaying reliable data. On the other hand drugs represent only a symptomatic treatment, therefore SIT is the only treatment which can alter the natural course of respiratory diseases.

Free PDF Download